Computer-Assisted Cognitive Behavioral Therapy for Depressed HIV+ People Taking Antiviral Medications (PRIME)

Computer-Assisted Cognitive Behavioral Therapy for Depressed  HIV+ People Taking Antiviral Medications (PRIME)

Brief description of study

The purpose of this research study is to determine the effectiveness of a form of psychotherapy (computer-assisted cognitive-behavior therapy) that uses a computer program for treatment for depression. The computer program is called Good Days Ahead (GDA). It is a web-based multimedia program that provides 8 sessions of Cognitive Behavior Therapy, an effective psychotherapy for treatment of depression. GDA is designed to help people learn the basic principles of cognitive-behavior therapy and build skills to help reduce their depression. Typically, it takes a person 1-2 hours to complete each of the 8 sessions. Because GDA is an internet based therapy, it does not require a therapist to deliver the treatment so is less costly and can be more widely used. We are hoping to learn whether people with HIV like the treatment and how it effects their depression.

Detailed description of study

Your involvement in the study will last between 9 and 17 weeks depending on the treatment group to which you are assigned. The entire study will take about 9 months to complete. This study has two parts: screening/baseline and the 8-week treatment with GDA. Half of the participants will get the treatment (GDA) immediately following the screening /baseline visit. The other half of participants will wait 8 weeks before starting the treatment (GDA).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Depression, Depression, HIV infection, Therapy
  • Age: Between 18 Years - 60 Years
  • Gender: All
Updated on 20 Jun 2016. Study ID: 821016

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center